May 22, 2018 06:15 PM EDT

House passes 'right-to-try' — allowing the terminally ill to ask companies for experimental drugs outside of FDA's purview

Zachary Brennan

Senior Editor

The House on Tuesday afternoon passed a Senate-ratified version of a bill, known as “right-to-try,” and President Donald Trump has indicated he will sign it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

House passes 'right-to-try' — allowing the terminally ill to ask companies for experimental drugs outside of FDA's purview

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

House pass­es 'right-to-try' — al­low­ing the ter­mi­nal­ly ill to ask com­pa­nies for ex­per­i­men­tal drugs out­side of FDA's purview

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

House passes 'right-to-try' — allowing the terminally ill to ask companies for experimental drugs outside of FDA's purview